EUVIMEDEUVIMED entdecken
Open Access

Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathways

Fan Yang, Yuangang Su, Jiamin Liang, Keyi Wang, Haoyu Lian, Junchun Chen, Jiake Xu, Jinmin Zhao, Qian Liu

International Journal of Molecular Medicine · 2023

DOI: 10.3892/ijmm.2023.5246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Medicine, 2023. Verfasst von Fan Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Research Centre for Regenerative Medicine, Department of Orthopaedics, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi …. Hauptthemen laut MEDLINE: Bone Resorption, Osteoporosis, Bone Diseases, Metabolic. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Postmenopausal osteoporosis is a systemic metabolic disease that chronically endangers public health and is typically characterized by low bone mineral density and marked bone fragility. The excessive bone resorption activity of osteoclasts is a major factor in the pathogenesis of osteoporosis; therefore, strategies aimed at inhibiting osteoclast activity may prevent bone decline and attenuate the process of osteoporosis. Casticin (Cas), a natural compound, has anti‑inflammatory and antitumor properties. However, the role of Cas in bone metabolism remains largely unclear. The present study found that the receptor activator of nuclear factor‑κΒ (NF‑κB) ligand‑induced osteoclast activation and differentiation were inhibited by Cas. Tartrate‑resistant acid phosphatase staining revealed that Cas inhibited osteoclast differentiation, and bone resorption pit assays demonstrated that Cas affected the function of osteoclasts. Cas significantly reduced the expression of osteoclast‑specific genes and related proteins, such as nuclear factor of activated T cells, cytoplasmic 1 and c‑Fos at the mRNA and protein level in a concentration‑dependent manner. Cas inhibited osteoclast formation by blocking the AKT/ERK and NF‑κB signaling pathways, according to the intracellular signaling analysis. The microcomputed tomography and tissue staining of tibiae from ovariectomized mice revealed that Cas prevented the bone loss induced by estrogen deficiency and reduced osteoclast activity in vivo. Collectively, these findings indicated that Cas may be used to prevent osteoporosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone ResorptionOsteoporosisBone Diseases, MetabolicFemaleAnimalsMiceHumansOsteogenesisNF-kappa BProto-Oncogene Proteins c-aktX-Ray MicrotomographySignal TransductionOsteoclastsCell DifferentiationOvariectomyRANK LigandFlavonoids

Stichwörter der Autor:innen

AKTERKNF‑κBcasticinosteoclastosteoporosis

Substanzen

NF-kappa BProto-Oncogene Proteins c-aktRANK LigandcasticinFlavonoids

Autor:innen und Institutionen

  • Research Centre for Regenerative Medicine, Department of Orthopaedics, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China.
  • School of Biomedical Sciences, The University of Western Australia, Perth 6009, Australia.

Zitieren

APA

Yang, F., Su, Y., Liang, J., Wang, K., Lian, H., Chen, J., Xu, J., Zhao, J., & Liu, Q. (2023). Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathways. International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2023.5246

Vancouver

Yang F, Su Y, Liang J, Wang K, Lian H, Chen J, et al. Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathways. International Journal of Molecular Medicine. 2023. doi:10.3892/ijmm.2023.5246

BibTeX
@article{Yang2023,
  author = {Yang, Fan and Su, Yuangang and Liang, Jiamin and Wang, Keyi and Lian, Haoyu and Chen, Junchun and Xu, Jiake and Zhao, Jinmin and Liu, Qian},
  title = {Casticin suppresses RANKL‑induced osteoclastogenesis and prevents ovariectomy‑induced bone loss by regulating the AKT/ERK and NF‑κB signaling pathways},
  journal = {International Journal of Molecular Medicine},
  year = {2023},
  doi = {10.3892/ijmm.2023.5246}
}
Kostenlos starten →